Fecal Transplant Overcomes Nivolumab Resistance in Melanoma Fecal Transplant Overcomes Nivolumab Resistance in Melanoma

"We were surprised by the clinical results," say researchers reporting a small trial involving 10 patients with refractory metastatic melanoma, three of whom again experienced treatment response.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news